We partner with early stage ventures to build companies that transform lives and industries.
Today we remain committed to our vision of identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders.
Our team is dedicated to attracting and supporting imaginative and focused entrepreneurs and startups with never-been-done-before ideas. Group companies benefit from our combined technological, strategic, entrepreneurial & business expertise, broad networks, and wide attention span.
A word from our founder
Where We Invest
RDC was founded in 1993 by Elron and Rafael, a global leader of defense technologies and one of Israel's largest defense companies. RDC combines Rafael's scale and technological edge, with Elron's vast expertise in helping startups develop into leading tech companies.
Through RDC, which has exclusive rights to commercialize Rafael's defense technologies in civilian markets, we initiate and develop new companies, and provide essential support from start to exit.
Since its inception, RDC has successfully invested in numerous hi-tech companies. A prime example of RDC's active end-to-end involvement in the growth of its companies is Given Imaging. Given Imaging redefined gastrointestinal disease diagnosis by developing the PillCam ingestible video capsule, based on a unique technology initially invented for military purposes. After becoming a world leader in its field, Given Imaging was acquired for $1 billion.
How We Invest
We aim high.
We invest primarily in early stage ventures with significant exit potential, in which we seek significant shareholder stakes, enabling us to provide hands-on support and contribute from our experience.
We become involved.
We play a defining role in the development of our group companies, by means of active involvement in all aspects of their business and day-to-day operations, to help them reach their long-term objectives.
We are committed.
As an operational holding company that invests its own capital in new and existing group companies, we have the flexibility to support the growth of our group companies over the long term, weather setbacks, and maximize exit events.
value of exit transactions since 2010
investments since 2010
dividends distributed since 2010
M&As since 2010
total amount invested in current group companies
Elron was founded in 1962 by Uzia Galil (Israel Prize recipient) as a result of his decisive commitment to bridge the gap between Israeli R&D and industry, and create “a knowledge-based industry” (later named hi-tech…). Uzia succeeded in raising initial funds of $160,000. By the end of the decade, Elron had 500 employees and 7 holdings in the fields of defense, computers, medtech & electronics, and was represented in over 80 cities in 6 continents.
1962: Elron is established
1966: Elron founds Elbit, the first Israeli commercial venture in the computer field, with a primary focus on defense, medical & communications technologiesToday Elbit Systems (NASDAQ: ESLT) is the largest non-government-owned defense company in Israel.
Pioneering Medical Imaging
In 1969, Elbit spun-off Elscint, which grew to become a world leader in the development of medical imaging technologies, forging a new technology: Computer Tomography (CT). In just over 10 years, the company achieved major breakthroughs, overshadowing the competition by reducing the scanning operation to seconds. It also entered the realm of ultrasound.
1972: Elscint goes public, becoming the first Israeli company to list on Nasdaq
1975: Elron follows suit, going public on the Tel Aviv Stock ExchangeBefore its sale in 1999, Elscint enjoyed a 10% world market share, had $300 million in revenues, and 3,000 employees.
By the 1980s, Elron had devised a strategy of nursing in-house projects to be later spun-off (in time to be known as an “incubator”…). During these years, Elron established Oprotech, which pioneered automated optical inspection of printed circuit boards, and was actively involved in the early stages of the establishment of Zoran, a pioneer in the development of digital signal processing (DSP) technology.
1981: Elron invests in Zoran (merged with CSR in 2011, LSE: CSR)
1981: Elron establishes Oprotech (today Orbotech, NASDAQ: ORBK)
1983: Elron invests in Zoran (merged with CSR in 2011, LSE: CSR)At the close of the decade, Elron had $420 million in aggregate annual sales.
Driven by its commitment to “building on the successes of the past while anticipating future trends”, in the early 1990s, Elron was one of the internet pioneers in Israel, expanding into information technologies and communications by the end of the decade. Landmark companies founded by Elron during these years include Partner Communication, Israel’s first GSM operator, and NetVision, Israel’s first – and later largest – ISP.
1993: Rafael Development Corporation (RDC) is established to commercialize Israeli MoD technologies in civilian markets
1994: Elron founds NetVision (merged with CellCom in 2011, NYSE: CEL)
1997: Elron founds Partner Communication (NASDAQ: PTNR)By the mid-1990s Elron had $1.2 billion in aggregate annual sales.
Pioneering Medical Devices
Through RDC, a joint subsidiary of Elron and Rafael (Israel’s 2nd largest defense company after Elbit Systems) which has exclusive rights to commercialize Rafael’s technologies in civilian markets, Elron has incubated and developed several technology leaders, most notably in the field of medical devices. Given Imaging redefined gastrointestinal disease diagnosis by developing the PillCam ingestible video capsule. Another RDC success is Medingo, which developed a miniature, lightweight insulin pump.
2001: Given Imaging goes public, and is the 1st company to list on the Nasdaq following 9/11
2005: Medingo, developer of an insulin micro-pump, is founded by RDCIn the 2000s, Elron added BrainsGate and Pocared to its portfolio, as part of its strategy of investing in transformative medtech startups.
Building tomorrow’s leaders
Today, we have significant holdings in a select number of start-up companies with disruptive potential. We are constantly and actively looking at new exciting ventures in order to continue and build tomorrow’s technology leaders. We continue to target investments in the medical devices field, and have also expanded our focus to the cyber space.
Nerve stimulation could provide new treatment option for most common type of stroke
May 24, 2019
BrainsGate’s pivotal study, ImpACT-24B, was published today in The LancetRead More
Nitinotes Presents First in Human Results at Digestive Disease Week 2019 in San Diego
May 18, 2019
The first in human study suggests that the Endozip™ is safe and effective in suturing of the stomach, and shows encouraging patient weight loss results in the short termRead More
Cloud-Native Security Innovator Alcide Expands Executive Leadership for Global Market Acceleration
May 15, 2019
Bolsters large-scale Kubernetes deployment and enterprise cloud transformation, migration and security expertiseRead More